cilostazol has been researched along with Prosthesis Durability in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cilostazol has been reported to reduce intimal hyperplasia and subsequent repeat revascularization." | 2.79 | Efficacy of two different self-expanding nitinol stents for atherosclerotic femoropopliteal arterial disease (SENS-FP trial): study protocol for a randomized controlled trial. ( Bae, JH; Baek, JY; Bong, JM; Cho, JH; Cho, YH; Choi, CU; Choi, HJ; Choi, SH; Choi, WG; Chung, WY; Her, SH; Kang, WY; Kim, EJ; Kim, JH; Kim, KC; Kim, MW; Kim, SM; Kim, WH; Kim, YH; Kim, YJ; Lee, SJ; Oh, DJ; Park, MW; Park, SH; Rha, SW; Seo, JB; Soh, JW; Suh, J, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, K | 1 |
| Miyazaki, S | 1 |
| Ishikawa, E | 1 |
| Mukai, M | 1 |
| Aoyama, D | 1 |
| Nodera, M | 1 |
| Kaseno, K | 1 |
| Tada, H | 1 |
| Park, SH | 1 |
| Rha, SW | 1 |
| Choi, CU | 1 |
| Kim, EJ | 1 |
| Oh, DJ | 1 |
| Cho, YH | 1 |
| Choi, WG | 1 |
| Lee, SJ | 1 |
| Kim, YH | 1 |
| Choi, SH | 1 |
| Kim, WH | 1 |
| Kim, KC | 1 |
| Cho, JH | 1 |
| Kim, JH | 1 |
| Kim, SM | 1 |
| Bae, JH | 1 |
| Bong, JM | 1 |
| Kang, WY | 1 |
| Baek, JY | 1 |
| Seo, JB | 1 |
| Chung, WY | 1 |
| Park, MW | 1 |
| Her, SH | 1 |
| Suh, J | 1 |
| Kim, MW | 1 |
| Kim, YJ | 1 |
| Choi, HJ | 1 |
| Soh, JW | 1 |
| Tara, S | 1 |
| Kurobe, H | 1 |
| de Dios Ruiz Rosado, J | 1 |
| Best, CA | 1 |
| Shoji, T | 1 |
| Mahler, N | 1 |
| Yi, T | 1 |
| Lee, YU | 1 |
| Sugiura, T | 1 |
| Hibino, N | 1 |
| Partida-Sanchez, S | 1 |
| Breuer, CK | 1 |
| Shinoka, T | 1 |
| Dihu, JB | 1 |
| Abudayyeh, I | 1 |
| Saudye, HA | 1 |
| Gurujal, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Self-Expanding Nitinol S.M.A.R.T-CONTROL Stent Versus Complete SE Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease : Prospective, Multicenter, Randomized, Controlled Trial (SENS-FP Trial)[NCT01570803] | 0 participants (Actual) | Interventional | 2013-01-31 | Withdrawn (stopped due to Study could not be initiated due to lack of research funding from the sponsors.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for cilostazol and Prosthesis Durability
| Article | Year |
|---|---|
Efficacy of two different self-expanding nitinol stents for atherosclerotic femoropopliteal arterial disease (SENS-FP trial): study protocol for a randomized controlled trial.
Topics: Alloys; Angioplasty, Balloon; Aspirin; Cilostazol; Clinical Protocols; Clopidogrel; Drug Therapy, Co | 2014 |
3 other studies available for cilostazol and Prosthesis Durability
| Article | Year |
|---|---|
Repetitive shock therapy of subcutaneous implantable cardioverter defibrillators in a patient with idiopathic ventricular fibrillation: What is the mechanism?
Topics: Ablation Techniques; Action Potentials; Anti-Arrhythmia Agents; Cilostazol; Defibrillators, Implanta | 2019 |
Cilostazol, Not Aspirin, Prevents Stenosis of Bioresorbable Vascular Grafts in a Venous Model.
Topics: Absorbable Implants; Animals; Aspirin; Blood Vessel Prosthesis; Cell Proliferation; Cilostazol; Dise | 2015 |
Cilostazol: a potential therapeutic option to prevent in-stent restenosis.
Topics: Cilostazol; Coronary Restenosis; Drug-Eluting Stents; Humans; Prosthesis Failure; Tetrazoles | 2011 |